# Intratumoral and Peritumoral Habitat Radiomics of MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy in Oral Squamous Cell Carcinoma

> **NCT06854107** · — · COMPLETED · sponsor: **Zilong Yuan** · enrollment: 225 (actual)

## Conditions studied

- Pathologic Complete Response

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06854107
- **Lead sponsor:** Zilong Yuan
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-01
- **Primary completion:** 2023-12-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 225 (ACTUAL)
- **Last updated:** 2025-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06854107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06854107, "Intratumoral and Peritumoral Habitat Radiomics of MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy in Oral Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06854107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*